Literature DB >> 36018501

Diet, Gut Microbiome, and Cognitive Decline.

Susan Ettinger1.   

Abstract

PURPOSE OF REVIEW: An epidemic of age-associated cognitive decline, most commonly ascribed to neurodegenerative conditions such as Alzheimer's and Parkinson's disease, is causing healthcare costs to soar and devastating caregivers. An estimated 6.5 million Americans are living today with Alzheimer's disease, with 13.8 million cases projected by mid-century. Although genetic mutations are known to cause neurodegeneration, autosomal dominant disease is very rare and most sporadic cases can be attributed, at least in part, to modifiable risk factors. RECENT
FINDINGS: Diet is a potential modifiable risk factor in cognitive decline. Food communicates with the brain through a complex signaling web involving multiple cells, mediators and receptors. Gut-brain communication is modulated by microorganisms including bacteria, archaea, viruses, and unicellular eukaryotes, which together constitute the microbiota. Microbes not only play major roles in the digestion and fermentation of the food, providing nutrients and bioactive metabolites, but also reflect the type and amount of food consumed and food-borne toxic exposures. Food components modify the diversity and abundance of the microbial populations, maintain the integrity of the gut barrier, and regulate the passage of microbes and their metabolites into the blood stream where they modulate the immune system and communicate with body systems including the brain. This paper will focus on selected mechanisms through which interactions between diet and the gut microbiota can modify brain integrity and cognitive function with emphasis on the pathogenesis of the most common dementia, Alzheimer's disease.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid; Copper; Dysbiosis; Flavonoids; Folate; Fructose; Gut microbiome; Gut-brain-axis signaling; Homocysteine; Hormesis; Hydrogen sulfide donors; Ketones; NAD; Polyphenols; Transsulfuration pathway; Vitamin B12; Vitamin B6

Year:  2022        PMID: 36018501     DOI: 10.1007/s13668-022-00435-y

Source DB:  PubMed          Journal:  Curr Nutr Rep        ISSN: 2161-3311


  69 in total

1.  Role of Polyphenols on Gut Microbiota and the Ubiquitin-Proteasome System in Neurodegenerative Diseases.

Authors:  Hanieh Nargeh; Fatemeh Aliabadi; Marjan Ajami; Hamidreza Pazoki-Toroudi
Journal:  J Agric Food Chem       Date:  2021-05-26       Impact factor: 5.279

Review 2.  Alzheimer's disease.

Authors:  Clive Ballard; Serge Gauthier; Anne Corbett; Carol Brayne; Dag Aarsland; Emma Jones
Journal:  Lancet       Date:  2011-03-01       Impact factor: 79.321

3.  Amyloid precursor protein dimerization and synaptogenic function depend on copper binding to the growth factor-like domain.

Authors:  Frederik Baumkötter; Nadine Schmidt; Carolyn Vargas; Sandra Schilling; Rebecca Weber; Katja Wagner; Sebastian Fiedler; Wilfried Klug; Jens Radzimanowski; Sebastian Nickolaus; Sandro Keller; Simone Eggert; Klemens Wild; Stefan Kins
Journal:  J Neurosci       Date:  2014-08-13       Impact factor: 6.167

Review 4.  Clearance systems in the brain-implications for Alzheimer disease.

Authors:  Jenna M Tarasoff-Conway; Roxana O Carare; Ricardo S Osorio; Lidia Glodzik; Tracy Butler; Els Fieremans; Leon Axel; Henry Rusinek; Charles Nicholson; Berislav V Zlokovic; Blas Frangione; Kaj Blennow; Joël Ménard; Henrik Zetterberg; Thomas Wisniewski; Mony J de Leon
Journal:  Nat Rev Neurol       Date:  2015-07-21       Impact factor: 42.937

Review 5.  The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.

Authors:  Giovanni B Frisoni; Daniele Altomare; Dietmar Rudolf Thal; Federica Ribaldi; Rik van der Kant; Rik Ossenkoppele; Kaj Blennow; Jeffrey Cummings; Cornelia van Duijn; Peter M Nilsson; Pierre-Yves Dietrich; Philip Scheltens; Bruno Dubois
Journal:  Nat Rev Neurosci       Date:  2021-11-23       Impact factor: 34.870

6.  The APP Intracellular Domain Is Required for Normal Synaptic Morphology, Synaptic Plasticity, and Hippocampus-Dependent Behavior.

Authors:  Maja Klevanski; Ulrike Herrmann; Sascha W Weyer; Romain Fol; Nathalie Cartier; David P Wolfer; John H Caldwell; Martin Korte; Ulrike C Müller
Journal:  J Neurosci       Date:  2015-12-09       Impact factor: 6.167

7.  Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.

Authors:  Yang Xiang; Xian-Le Bu; Yu-Hui Liu; Chi Zhu; Lin-Lin Shen; Shu-Sheng Jiao; Xiao-Yan Zhu; Brian Giunta; Jun Tan; Wei-Hong Song; Hua-Dong Zhou; Xin-Fu Zhou; Yan-Jiang Wang
Journal:  Acta Neuropathol       Date:  2015-09-12       Impact factor: 17.088

Review 8.  The genetic landscape of Alzheimer disease: clinical implications and perspectives.

Authors:  Caroline Van Cauwenberghe; Christine Van Broeckhoven; Kristel Sleegers
Journal:  Genet Med       Date:  2015-08-27       Impact factor: 8.822

Review 9.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

10.  A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.

Authors:  Tiffany A Thibaudeau; Raymond T Anderson; David M Smith
Journal:  Nat Commun       Date:  2018-03-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.